Literature DB >> 25521218

The atypical MAPK ERK3 controls positive selection of thymocytes.

Julien Sirois1, Jean-François Daudelin, Salix Boulet, Miriam Marquis, Sylvain Meloche, Nathalie Labrecque.   

Abstract

Extracellular signal-regulated kinase 3 (ERK3 )is an atypical member of the mitogen-activated protein kinase (MAPK) family. We have previously shown that ERK3 is expressed during thymocyte differentiation and that its expression is induced in mature peripheral T cells following activation of ERK1/2 by T-cell receptor (TCR) signalling. Herein, we have investigated whether ERK3 expression is required for proper T-cell selection. Using a knock-in mouse model in which the coding sequence of ERK3 is replaced by the gene encoding for the β-galactosidase reporter, we show that ERK3 is expressed by double-positive (DP) thymocytes undergoing positive selection. In ERK3-deficient mice with a polyclonal TCR repertoire, we observe a decrease in positive selection. This reduction in positive selection was also observed when ERK3-deficient mice were backcrossed to class I- and class II-restricted TCR transgenic mice. Furthermore, the response of DP thymocytes to in vitro TCR stimulation was strongly reduced in ERK3-deficient mice. Together, these results show that ERK3 expression following TCR signalling is critical for proper thymic positive selection.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  mitogen-activated protein kinases; positive selection; thymus

Mesh:

Substances:

Year:  2015        PMID: 25521218      PMCID: PMC4405333          DOI: 10.1111/imm.12433

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  Positive and negative selection of T cells.

Authors:  Timothy K Starr; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2002-10-16       Impact factor: 28.527

2.  A motif in the alphabeta T-cell receptor controls positive selection by modulating ERK activity.

Authors:  G Werlen; B Hausmann; E Palmer
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

Review 3.  Molecular and genetic parameters defining T-cell clonal selection.

Authors:  Nathalie Labrecque; Troy Baldwin; Sylvie Lesage
Journal:  Immunol Cell Biol       Date:  2010-10-19       Impact factor: 5.126

4.  Regulation of Zap70 expression during thymocyte development enables temporal separation of CD4 and CD8 repertoire selection at different signaling thresholds.

Authors:  Manoj Saini; Charles Sinclair; Daniel Marshall; Mauro Tolaini; Shimon Sakaguchi; Benedict Seddon
Journal:  Sci Signal       Date:  2010-03-23       Impact factor: 8.192

5.  IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization.

Authors:  Marie-Hélène Lacombe; Marie-Pierre Hardy; Julie Rooney; Nathalie Labrecque
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

6.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

Authors:  G Pagès; S Guérin; D Grall; F Bonino; A Smith; F Anjuere; P Auberger; J Pouysségur
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  Inhibition of T cell receptor expression and function in immature CD4+CD8+ cells by CD4.

Authors:  T Nakayama; C H June; T I Munitz; M Sheard; S A McCarthy; S O Sharrow; L E Samelson; A Singer
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

8.  Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 beta-phorbol 12-myristate 13-acetate-induced phosphorylation and activation.

Authors:  C E Whitehurst; T G Boulton; M H Cobb; T D Geppert
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

9.  MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.

Authors:  C E Whitehurst; T D Geppert
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

10.  T cell receptor antagonist peptides induce positive selection.

Authors:  K A Hogquist; S C Jameson; W R Heath; J L Howard; M J Bevan; F R Carbone
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

View more
  7 in total

1.  Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.

Authors:  Simon Mathien; Paul Déléris; Mathilde Soulez; Laure Voisin; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

2.  Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.

Authors:  A Kotlyarov; M Gaestel; N Ronkina; K Schuster-Gossler; F Hansmann; H Kunze-Schumacher; I Sandrock; T Yakovleva; J Lafera; W Baumgärtner; A Krueger; I Prinz; A Gossler
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

3.  A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.

Authors:  Lobna Elkhadragy; Minyi Chen; Kennon Miller; Muh-Hwa Yang; Weiwen Long
Journal:  Mol Oncol       Date:  2017-01-12       Impact factor: 6.603

4.  Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2.

Authors:  Maria Perander; Rania Al-Mahdi; Thomas C Jensen; Jennifer A L Nunn; Hanne Kildalsen; Bjarne Johansen; Mads Gabrielsen; Stephen M Keyse; Ole-Morten Seternes
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

5.  Identification of Crucial Hub Genes and Differential T Cell Infiltration in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Strategies.

Authors:  Xiaomei Yang; Cheng Wang; Yicheng Lin; Peng Zhang
Journal:  Front Mol Biosci       Date:  2022-01-20

6.  miR-200a-5p regulates myocardial necroptosis induced by Se deficiency via targeting RNF11.

Authors:  Tianshu Yang; Changyu Cao; Jie Yang; Tianqi Liu; Xin Gen Lei; Ziwei Zhang; Shiwen Xu
Journal:  Redox Biol       Date:  2017-12-08       Impact factor: 11.799

7.  The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.

Authors:  Lobna Elkhadragy; Hadel Alsaran; Weiwen Long
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.